Tracerbio
1 known investors
Tracer offers software that turns NGS sequencers (e.g. NovaSeq, Ultima, MGI) or dPCR systems into ctDNA/tumor-fraction analysis tools, converting raw sequencing data into quantitative Tumor Fraction and MRD (minimal residual disease) reports via cloud or on-premise deployment. It targets precision oncology research and clinical labs, using generic WGS/dPCR reagents to enable decentralized, tissue-free cancer monitoring.</parameter> <parameter name="founders">[]
Investors · 1
.jpeg){kind=logo}
Frequently asked questions
- What does Tracerbio do?
- Tracer offers software that turns NGS sequencers (e.g. NovaSeq, Ultima, MGI) or dPCR systems into ctDNA/tumor-fraction analysis tools, converting raw sequencing data into quantitative Tumor Fraction and MRD (minimal residual disease) reports via cloud or on-premise deployment. It targets precision oncology research and clinical labs, using generic WGS/dPCR reagents to enable decentralized, tissue-free cancer monitoring.</parameter> <parameter name="founders">[]
- Who are Tracerbio's investors?
- Tracerbio's investors include Impatient Ventures.